beta-Hydroxybutyric acid sodium salt

We are beta-Hydroxybutyric acid sodium salt CAS:150-83-4 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Product Name: beta-Hydroxybutyric acid sodium salt
Other Name:
DL-3-Hydroxybutyric acid sodium salt;
Sodium 3-hydroxybutyrate;
CAS No: 150-83-4
MF: C4H7NaO3
MW: 126.086
Density: N/A
Boiling point: 269.2ºC at 760mmHg
Melting point: 165-167ºC
Flash point: 121ºC
UN Number: Not dangerous goods.
UN Proper Shipping Name: Not dangerous goods.
Transport hazard class: Not dangerous goods.
Packing group: Not dangerous goods.
 
Specification
Appearance: White powder
Assay: ≥99.0%
 
Application
Health supplements, as a nutritional supplement, can improve blood ketone body levels and improve athletes' endurance, mental performance and energy levels.
 
Package: 25kg/drum, can also be designed according to customer requirements.
Storage: Store in cool place. Keep container tightly closed in a dry and well-ventilated place.

beta-Hydroxybutyric acid sodium salt


Related News: The chemical compound which is in the process of becoming an API from a raw material is called an intermediate.acetone oxime CAS:127-06-0 Inceptua is a pharmaceutical company and service partner spanning throughout the product lifecycle – from comparator sourcing for clinical trials, through early access programs to licensing and commercialization for products.3,4-Dimethoxyaniline CAS:6315-89-5 With the improvement of domestic GMP management level, the increase of process development capabilities and international certification experience, China has already possessed the conditions for developing characteristic APIs.5-bromopentan-1-ol CAS:34626-51-2 Profitability continued to improve. The company’s comprehensive gross profit margin for the first three quarters was 36.06%, a year-on-year increase of 3.44 percentage points. Since this year, the company’s profitability has remained at a relatively high level. On the one hand, due to the decline in the trading business with lower profitability, the proportion has declined.GlaxoSmithKline’s HIV drugs division ViiV Healthcare said on Saturday that the U.S. Food and Drug Administration declined to approve its long acting HIV injection.

Related Products
Product Name
3-Bromo-5-chloropyridine View Details
Triptorelin acetate View Details
2’-Deoxycytidine 5’-Triphosphate Disodium Salt View Details
1,4-Dibromobutane manufacturer ethyl (1S,3aR,6aS)-octahydrocyclopenta[c]pyrrole-1-carboxylate hydrochloride manufacturer 3-Fluoro-4-aminobenzonitrile manufacturer 2-(4-chlorophenyl)-3-methylbutanenitrile manufacturer 4-Cyanobenzyl bromide manufacturer